Drug news
Implanted SPR Micropulse System shows benefit for patient with Post-Stroke Shoulder Pain
Doctors involved in a multi-centre clinical study for the treatment of Post-Stroke Shoulder Pain have made the first implantation of the Micropulse system, an investigational pain therapy device from SPR Therapeutics. SPR's short-term, temporary therapy significantly reduced his pain after just a few weeks but when SPR's fully implantable device was implanted into the patient, he was pain-free within a few weeks of surgery. SPR Therapeutic's investigational system uses a proprietary method of Intramuscular Nerve Therapy which stimulates peripheral nerves within muscle to treat pain, and is being studied in a clinical study to evaluate the safety and effectiveness of this fully implantable therapy in a group of subjects with post-stroke shoulder pain who are unresponsive to or cannot tolerate conventional therapies.